These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23324342)

  • 1. P-TEFb as a target to reactivate latent HIV: two Brds are now in hand.
    Rice AP
    Cell Cycle; 2013 Feb; 12(3):392-3. PubMed ID: 23324342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new BET on the control of HIV latency.
    Karn J
    Cell Cycle; 2013 Feb; 12(4):545-6. PubMed ID: 23370386
    [No Abstract]   [Full Text] [Related]  

  • 3. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
    Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
    Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency.
    Li Z; Mbonye U; Feng Z; Wang X; Gao X; Karn J; Zhou Q
    PLoS Pathog; 2018 Apr; 14(4):e1007012. PubMed ID: 29684085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV latency reversing agents act through Tat post translational modifications.
    Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
    Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter.
    Wu J; Ao MT; Shao R; Wang HR; Yu D; Fang MJ; Gao X; Wu Z; Zhou Q; Xue YH
    Sci Rep; 2017 Sep; 7(1):10657. PubMed ID: 28878233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
    Li Z; Guo J; Wu Y; Zhou Q
    Nucleic Acids Res; 2013 Jan; 41(1):277-87. PubMed ID: 23087374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
    O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
    J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.
    Fong YW; Zhou Q
    Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of latent HIV-1 by inhibition of BRD4.
    Zhu J; Gaiha GD; John SP; Pertel T; Chin CR; Gao G; Qu H; Walker BD; Elledge SJ; Brass AL
    Cell Rep; 2012 Oct; 2(4):807-16. PubMed ID: 23041316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
    Asamitsu K; Okamoto T
    Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation.
    Ping YH; Rana TM
    J Biol Chem; 2001 Apr; 276(16):12951-8. PubMed ID: 11112772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.
    Zhou M; Huang K; Jung KJ; Cho WK; Klase Z; Kashanchi F; Pise-Masison CA; Brady JN
    J Virol; 2009 Jan; 83(2):1036-44. PubMed ID: 18971272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir.
    Lin X; Irwin D; Kanazawa S; Huang L; Romeo J; Yen TS; Peterlin BM
    J Virol; 2003 Aug; 77(15):8227-36. PubMed ID: 12857891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.
    Brès V; Gomes N; Pickle L; Jones KA
    Genes Dev; 2005 May; 19(10):1211-26. PubMed ID: 15905409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tat, Tat-associated kinase, and transcription.
    Jeang KT
    J Biomed Sci; 1998; 5(1):24-7. PubMed ID: 9570510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.
    Bourgeois CF; Kim YK; Churcher MJ; West MJ; Karn J
    Mol Cell Biol; 2002 Feb; 22(4):1079-93. PubMed ID: 11809800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.